NewsBenzingaPharming verengt die Umsatzprognose für das Geschäftsjahr 2026 von 375,000 Mio. USD bis 395,000 Mio. USD auf 380,000 Mio. USD bis 390,000 Mio. USD gegenüber der Schätzung von 389,333 Mio. USD Pharming verengt die Umsatzprognose für das Geschäftsjahr 2026 von 375,000 Mio. USD bis 395,000 Mio. USD auf 380,000 Mio. USD bis 390,000 Mio. USD gegenüber der Schätzung von 389,333 Mio. USD Benzinga 2026.10.22 05:29 (GMT+0) Open on Benzinga Other news Morning Bid: Jensen Huang's last hurrah, and a nervy future for Nvidia 'Business as usual': Nvidia's Kress passes first test as board slams door on Huang Ethereum spot ETFs see total net outflow of $29.0903M yesterday, marking 3 consecutive days of net outflows Paytaca: Backend Systems Attacked but User Funds and Private Keys Unaffected, Warns Against Interacting with Suspicious Orders ‘Not Under Systemic Attack’: Marco Rubio Says ‘Zero Evidence’ Microsoft, JPMorgan and FAA Outages Due to Hostile Actors First American Financial Corporation (FAF) Presents at 2026 Stephens Annual Investment Conference | NASH2026 Transcript
Ethereum spot ETFs see total net outflow of $29.0903M yesterday, marking 3 consecutive days of net outflows
Paytaca: Backend Systems Attacked but User Funds and Private Keys Unaffected, Warns Against Interacting with Suspicious Orders
‘Not Under Systemic Attack’: Marco Rubio Says ‘Zero Evidence’ Microsoft, JPMorgan and FAA Outages Due to Hostile Actors
First American Financial Corporation (FAF) Presents at 2026 Stephens Annual Investment Conference | NASH2026 Transcript